We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
-3.84%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$6.16B
AUM Growth
+$1.7B
Cap. Flow
+$2.17B
Cap. Flow %
35.15%
Top 10 Hldgs %
26.62%
Holding
7,028
New
630
Increased
3,221
Reduced
2,151
Closed
574

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$204M
2
MSFT icon
Microsoft
MSFT
+$195M
3
AMZN icon
Amazon
AMZN
+$97.4M
4
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$95M
5
TSM icon
TSMC
TSM
+$69.5M

Sector Composition

Rank Sector Weight
1 Technology 27%
2 Healthcare 10.88%
3 Consumer Discretionary 10.71%
4 Financials 8.69%
5 Communication Services 7.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ATCX
3201
DELISTED
Atlas Technical Consultants, Inc. Class A Common Stock
ATCX
$48K ﹤0.01%
7,221
-5,365
-43% -$38.4K
CRHC
3202
DELISTED
Cohn Robbins Holdings Corp.
CRHC
$48K ﹤0.01%
4,810
-1,563
-25% -$15.1K
BCH icon
3203
Banco de Chile
BCH
$20.5B
$47K ﹤0.01%
2,663
+2,199
+474% +$40.6K
BDN
3204
Brandywine Realty Trust
BDN
$542M
$47K ﹤0.01%
6,992
-6,641
-49% -$56.7K
BORR
3205
Borr Drilling
BORR
$1.36B
$47K ﹤0.01%
14,059
+8,591
+157% +$31.9K
BRDG
3206
DELISTED
Bridge Investment Group
BRDG
$47K ﹤0.01%
3,257
-757
-19% -$12.2K
CLB icon
3207
Core Laboratories
CLB
$581M
$47K ﹤0.01%
3,452
-29,268
-89% -$493K
CMRE icon
3208
Costamare
CMRE
$1.76B
$47K ﹤0.01%
5,290
+3,232
+157% +$35.6K
CPNG icon
3209
Coupang
CPNG
$29.1B
$47K ﹤0.01%
2,855
-16,236
-85% -$281K
CSTL icon
3210
Castle Biosciences
CSTL
$917M
$47K ﹤0.01%
1,821
+691
+61% +$19.4K
CWCO icon
3211
Consolidated Water Co
CWCO
$501M
$47K ﹤0.01%
3,045
+2,937
+2,719% +$46.3K
IFS icon
3212
Intercorp Financial Services
IFS
$5.99B
$47K ﹤0.01%
+2,353
New +$53.5K
IX icon
3213
ORIX
IX
$43.6B
$47K ﹤0.01%
3,315
+1,210
+57% +$19.8K
MAIN icon
3214
Main Street Capital
MAIN
$5.5B
$47K ﹤0.01%
1,407
-169
-11% -$6.96K
MCHX icon
3215
Marchex
MCHX
$81.5M
$47K ﹤0.01%
27,969
+2,130
+8% +$4.1K
MOFG
3216
DELISTED
MidWestOne Financial Group
MOFG
$47K ﹤0.01%
1,733
+1,092
+170% +$33.4K
NKTR icon
3217
Nektar Therapeutics
NKTR
$2.53B
$47K ﹤0.01%
971
+437
+82% +$26K
NYAX
3218
Nayax
NYAX
$1.94B
$47K ﹤0.01%
+1,996
New +$51.4K
OMAB icon
3219
Grupo Aeroportuario Centro Norte
OMAB
$5.08B
$47K ﹤0.01%
+936
New +$49.1K
SILC icon
3220
Silicom
SILC
$281M
$47K ﹤0.01%
1,344
+1,076
+401% +$41.4K
SKE
3221
Skeena Resources
SKE
$4.15B
$47K ﹤0.01%
9,891
+4,338
+78% +$22.1K
TLS icon
3222
Telos
TLS
$336M
$47K ﹤0.01%
5,235
+753
+17% +$6.94K
VHT icon
3223
Vanguard Health Care ETF
VHT
$18.9B
$47K ﹤0.01%
212
-197
-48% -$47K
ZIMV
3224
DELISTED
ZimVie
ZIMV
$47K ﹤0.01%
4,782
-1,083
-18% -$17.5K
LUNA
3225
DELISTED
Luna Innovations Incorporated
LUNA
$47K ﹤0.01%
+10,481
New +$59.9K

Similar funds

Tower Research Capital (TRC)'s Q3 2022 Portfolio in Review

As of Q3 2022, Tower Research Capital (TRC) held 7,028 positions worth $6.16B, up 38% from $4.46B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Tower Research Capital (TRC) deployed $2.17B of net new capital in Q3 2022, opening 630 new positions and adding to 3,221 existing holdings. Its largest new stake was iShares Core S&P Mid-Cap ETF: 347,965 shares worth $15.3M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 23% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $53M trimmed.

  • Tower Research Capital (TRC)'s largest Q3 2022 buy was iShares Core S&P Mid-Cap ETF: 347,965 shares worth $15.3M.
  • Tower Research Capital (TRC) added most to Apple in Q3 2022, an estimated $204M increase.
  • Tower Research Capital (TRC)'s biggest Q3 2022 reduction was iShares Russell 2000 ETF, cutting an estimated $53M.
  • Tower Research Capital (TRC) fully exited State Street SPDR Portfolio S&P 500 ETF in Q3 2022, selling an estimated $6.39M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 27% of its $6.16B portfolio in Q3 2022.
  • Tower Research Capital (TRC) opened 630 new positions and closed 574 in Q3 2022.
  • Tower Research Capital (TRC)'s portfolio value rose 38% quarter-over-quarter to $6.16B.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2022, filed 10 Nov 2022.